Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iterum Therapeutics Plc (NQ: ITRM )

0.9500 +0.0100 (+1.06%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 132,916
Open 0.9400
Bid (Size) 0.9200 (190)
Ask (Size) 0.9500 (1)
Prev. Close 0.9400
Today's Range 0.8900 - 1.030
52wk Range 0.6011 - 7.017
Shares Outstanding 12,705,961
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with an overview of the biggest pre-market stock movers traders need to know about for Monday! 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga

Performance

YTD
+3.24%
+3.24%
1 Month
-16.67%
-16.67%
3 Month
+34.81%
+34.81%
6 Month
-42.07%
-42.07%
1 Year
-83.50%
-83.50%

More News

Read More
Iterum Therapeutics Reports Employment Inducement Grant
From Iterum Therapeutics plc
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Iterum Therapeutics Shares Are Surging - Read Why
Via Benzinga
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem
From Iterum Therapeutics plc
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Iterum Therapeutics Reports Third Quarter 2022 Financial Results
From Iterum Therapeutics plc
Via Globe NewsWire
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022
From Iterum Therapeutics plc
Via Globe NewsWire
Iterum Announces First Patient Dosed in REASSURE, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
From Iterum Therapeutics plc
Via Globe NewsWire
Iterum Therapeutics to Present Data at IDWeek 2022
From Iterum Therapeutics plc
Via Globe NewsWire
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
Via Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Boeing, PriceSmart And 80 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
This Healthcare Stock is Surging By Over 21%: Here's 24 Biggest Movers In Tuesday's Pre-Market
Via Benzinga
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
Via Benzinga
Dow Dips Around 90 Points; La Jolla Pharmaceutical Shares Surge
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.